Recombinant DegV domain-containing protein SPy_1936/M5005_Spy1650 (SPy_1936, M5005_Spy1650)

What is the DegV domain-containing protein SPy_1936/M5005_Spy1650 and what organism does it originate from?

The DegV domain-containing protein SPy_1936/M5005_Spy1650 is a protein found in Streptococcus pyogenes serotype M1, a gram-positive bacterial pathogen that causes various human infections. This protein contains a DegV domain, which is typically associated with fatty acid binding capabilities. The full-length protein consists of 286 amino acids with a molecular weight of approximately 31,380 Da . The protein is categorized in the DegV family of proteins, which are widely distributed across bacterial species and believed to play roles in lipid metabolism.

What is the putative function of SPy_1936/M5005_Spy1650?

Based on UniProt annotations and structural similarities to other DegV domain-containing proteins, SPy_1936/M5005_Spy1650 may bind long-chain fatty acids, such as palmitate, and likely plays a role in lipid transport or fatty acid metabolism within S. pyogenes . The specific biological function of this protein remains to be fully characterized through detailed biochemical and structural studies. Understanding its precise role could provide insights into S. pyogenes metabolism and potentially its pathogenicity mechanisms.

What expression systems are commonly used for producing recombinant SPy_1936/M5005_Spy1650?

Recombinant SPy_1936/M5005_Spy1650 can be produced using several expression systems, each with distinct advantages depending on specific research requirements:

The choice of expression system should be guided by the specific experimental requirements, downstream applications, and the level of native protein conformation needed . For most basic biochemical characterizations, E. coli-derived protein is sufficient, while more complex studies may benefit from higher eukaryotic expression systems.

What are the optimal conditions for storage and handling of recombinant SPy_1936/M5005_Spy1650?

For optimal stability and functionality of recombinant SPy_1936/M5005_Spy1650, the following storage and handling protocols are recommended:

• Store lyophilized protein at -20°C or -80°C for long-term storage

• Keep working aliquots at 4°C for up to one week to minimize freeze-thaw cycles

• If the protein becomes entrapped in the seal of the product vial during storage, briefly centrifuge the vial to dislodge any liquid in the container's cap

• Reconstitute lyophilized protein in appropriate buffer systems (typically pH 7.0-7.5)

• Consider adding stabilizers such as glycerol (10-20%) when storing reconstituted protein

• Monitor protein stability using techniques like thermal shift assays or activity measurements

Avoiding repeated freeze-thaw cycles is particularly important as this can lead to protein denaturation, aggregation, and loss of activity. Creating single-use aliquots upon initial reconstitution is a recommended practice for maximizing protein stability and experimental reproducibility.

How can researchers investigate the fatty acid binding properties of SPy_1936/M5005_Spy1650?

To characterize the fatty acid binding properties of SPy_1936/M5005_Spy1650, researchers can employ several complementary methodological approaches:

• Fluorescence-based binding assays: Using environmentally sensitive fluorescent probes like 1-anilinonaphthalene-8-sulfonic acid (ANS) to detect conformational changes upon fatty acid binding.

• Isothermal Titration Calorimetry (ITC): This provides direct measurement of binding thermodynamics, including binding affinity (Kd), stoichiometry, and thermodynamic parameters (ΔH, ΔS).

• Surface Plasmon Resonance (SPR): Allows real-time monitoring of binding kinetics between the protein and immobilized fatty acids.

• Intrinsic tryptophan fluorescence: Measures changes in the protein's fluorescence emission spectra upon ligand binding, particularly useful if tryptophan residues are near the binding pocket.

• Circular Dichroism (CD): Assesses potential conformational changes in secondary structure upon fatty acid binding.

A systematic approach would involve:

• Testing binding against a panel of fatty acids of varying chain lengths (C8-C22) and saturation levels

• Including appropriate positive and negative controls

• Performing concentration-dependent experiments to determine binding affinity constants

• Correlating binding data with structural information when available

What methodological approaches can assess the role of SPy_1936/M5005_Spy1650 in Streptococcus pyogenes pathogenicity?

To investigate the potential role of SPy_1936/M5005_Spy1650 in S. pyogenes pathogenicity, a multi-faceted experimental approach should be employed:

• Gene knockout studies:

  • Generate SPy_1936 deletion mutants using homologous recombination or CRISPR-Cas9

  • Compare growth characteristics in various media conditions, especially lipid-limited media

  • Assess virulence factor production in wild-type versus mutant strains

• Complementation studies:

  • Reintroduce the wild-type gene to confirm phenotype restoration

  • Create point mutations in key residues to identify critical functional domains

• Infection models:

  • Compare wild-type and mutant strains in appropriate cell culture models

  • Assess adherence, invasion, and intracellular survival capabilities

  • Evaluate inflammatory responses using cytokine profiling

• Transcriptomic and proteomic analyses:

  • Perform RNA-Seq to identify genes differentially expressed in knockout versus wild-type strains

  • Use proteomics to identify changes in protein expression profiles

  • Focus on pathways related to lipid metabolism and virulence factor regulation

These approaches should be conducted with appropriate controls and statistical analyses to ensure robust and reproducible results that can establish causality between SPy_1936 function and pathogenic phenotypes.

What structural analyses can provide insights into the function of SPy_1936/M5005_Spy1650?

Structural analyses of SPy_1936/M5005_Spy1650 can provide critical insights into its function through various complementary techniques:

Table 1: Key structural features to analyze in SPy_1936/M5005_Spy1650

What is the recommended workflow for purifying recombinant SPy_1936/M5005_Spy1650 for structural studies?

A robust purification workflow for obtaining high-purity SPy_1936/M5005_Spy1650 suitable for structural studies typically involves:

• Expression optimization:

  • Test expression in E. coli, yeast, baculovirus, or mammalian systems based on experimental needs

  • Optimize expression conditions (temperature, induction time, media composition)

  • Consider fusion tags that enhance solubility if expression yields are low

• Initial purification:

  • Use appropriate lysis buffer (typically Tris-HCl pH 7.5, 150-300 mM NaCl, with protease inhibitors)

  • Perform affinity chromatography utilizing the affinity tag (His, GST, etc.)

  • Consider on-column tag cleavage if the tag might interfere with structural studies

• Secondary purification:

  • Ion exchange chromatography based on the protein's theoretical pI

  • Size exclusion chromatography to remove aggregates and ensure monodispersity

• Quality control:

  • SDS-PAGE to confirm purity (aim for >95%)

  • Mass spectrometry to verify protein identity and integrity

  • Thermal shift assay to assess protein stability

  • Activity assays to confirm functionality (fatty acid binding)

Table 2: Troubleshooting common purification issues with SPy_1936/M5005_Spy1650

How can researchers investigate the potential role of SPy_1936/M5005_Spy1650 in fatty acid metabolism of S. pyogenes?

To investigate the role of SPy_1936/M5005_Spy1650 in fatty acid metabolism, researchers should consider these methodological approaches:

• Metabolomic profiling:

  • Compare wild-type and SPy_1936 knockout strains using LC-MS/MS

  • Focus on lipid metabolites and fatty acid profiles

  • Perform analyses under different growth conditions and stressors

• Isotope labeling experiments:

  • Use 13C-labeled fatty acids to trace metabolic fates

  • Determine if SPy_1936 affects incorporation or utilization rates

  • Combine with metabolomic analysis to map metabolic fluxes

• Lipidomic analysis:

  • Quantify changes in membrane lipid composition in knockout versus wild-type

  • Assess phospholipid profiles and fatty acid chain length distribution

  • Correlate with membrane fluidity and permeability measurements

• Gene expression studies:

  • Use qRT-PCR to measure expression levels of SPy_1936 under different conditions

  • Assess co-regulation with other genes involved in lipid metabolism

  • Identify potential regulators using reporter gene assays

This multifaceted approach provides complementary data that can establish a comprehensive understanding of the protein's role in fatty acid metabolism and potentially connect it to bacterial physiology and pathogenicity.

What are the critical controls needed when studying SPy_1936/M5005_Spy1650 using recombinant protein?

When working with recombinant SPy_1936/M5005_Spy1650, the following controls are critical for experimental rigor:

• Expression system controls:

  • Empty vector control to account for host cell protein contamination

  • Comparison of protein expressed in different systems to assess impact of post-translational modifications

• Protein quality controls:

  • SDS-PAGE and Western blot to confirm protein identity and purity

  • Mass spectrometry to verify complete sequence

  • Circular dichroism to confirm proper folding

• Functional assay controls:

  • Denatured protein control to distinguish specific from non-specific activities

  • Site-directed mutants affecting predicted binding sites

  • Competition assays with unlabeled ligands

  • Positive control using a well-characterized homologous protein

• Binding specificity controls:

  • Panel of structurally related and unrelated fatty acids

  • Negative control proteins with similar size/charge but different function

• Data analysis controls:

  • Technical and biological replicates to ensure reproducibility

  • Dose-response curves to determine specificity versus non-specific binding

  • Statistical validation of all quantitative measurements

Implementing these controls ensures experimental rigor and facilitates the distinction between true biological effects and technical artifacts.

How can researchers design experiments to identify potential interaction partners of SPy_1936/M5005_Spy1650?

To identify potential interaction partners of SPy_1936/M5005_Spy1650, consider these experimental approaches:

• Affinity purification coupled with mass spectrometry (AP-MS):

  • Express tagged SPy_1936 in S. pyogenes or heterologous system

  • Perform pull-down experiments using antibodies against the tag

  • Identify co-purifying proteins by mass spectrometry

  • Use quantitative approaches to distinguish specific from non-specific interactions

• Bacterial two-hybrid system:

  • Provides relevant context for bacterial protein interactions

  • Can be performed in conditions mimicking S. pyogenes environment

• Proximity-dependent biotin identification (BioID):

  • Fuse SPy_1936 to a biotin ligase

  • Identify proximal proteins through biotinylation

  • Particularly useful for transient interactions

• Crosslinking mass spectrometry:

  • Use chemical crosslinkers to capture transient interactions

  • Identify crosslinked peptides by mass spectrometry

  • Provides insights into interaction interfaces

Table 3: Comparison of protein interaction detection methods for SPy_1936/M5005_Spy1650

Following identification of potential interaction partners, validation using orthogonal methods is essential to confirm true biological interactions.

What computational approaches can help predict the functional significance of SPy_1936/M5005_Spy1650?

Computational approaches offer valuable insights into the potential functions of SPy_1936/M5005_Spy1650:

• Sequence-based analyses:

  • Multiple sequence alignment with homologous DegV proteins

  • Identification of conserved residues as potential functional sites

  • Phylogenetic analysis to trace evolutionary relationships

  • Genomic context analysis to identify functionally related genes

• Structural bioinformatics:

  • Homology modeling based on crystallized DegV domain proteins

  • Binding site prediction using algorithms like CASTp or FTMap

  • Molecular docking with potential fatty acid ligands

  • Molecular dynamics simulations to assess protein stability and dynamics

• Network analyses:

  • Protein-protein interaction network prediction

  • Integration with known metabolic pathways

  • Co-expression network analysis using existing transcriptomic data

• Comparative genomics:

  • Analysis of gene presence/absence across Streptococcus species

  • Correlation with pathogenicity or niche adaptation

  • Identification of horizontal gene transfer events

These computational analyses should generate testable hypotheses that can be experimentally validated to establish the biological function of SPy_1936/M5005_Spy1650 with greater confidence.

How can researchers assess the potential of SPy_1936/M5005_Spy1650 as a drug target against S. pyogenes infections?

To evaluate SPy_1936/M5005_Spy1650 as a potential drug target, researchers should implement a systematic approach:

• Target validation:

  • Determine essentiality through knockout studies

  • If not essential, assess contribution to virulence or persistence

  • Evaluate growth defects under different conditions

  • Confirm expression during infection using transcriptomics/proteomics

• Druggability assessment:

  • Analyze binding pocket characteristics (volume, hydrophobicity)

  • Assess conservation across Streptococcus species

  • Compare with human homologs to predict potential off-target effects

  • Perform virtual screening to estimate ligandability

• Assay development:

  • Establish robust biochemical assays for high-throughput screening

  • Develop cellular assays to monitor protein function

  • Create reporter systems to measure activity inhibition

• Small molecule screening:

  • Perform fragment-based screening using NMR or X-ray crystallography

  • Conduct high-throughput screening of chemical libraries

Table 4: Evaluation criteria for SPy_1936/M5005_Spy1650 as a drug target

This systematic approach enables researchers to make informed decisions about the viability of SPy_1936/M5005_Spy1650 as a drug target and the most promising strategies for inhibitor development.